Functional responses to expression of TEL/PDGFbetaR are modified in the presence of cytokine and involve mitogen-activated protein kinases
Global down-regulation of HOX gene expression in acute promyelocytic leukaemia identified by real-time PCR
Mutations in SBDS cause Shwachman-Diamond syndrome
Transcription factor occupancy and chromatin fine structure alterations at the c-FMS (CSF-1 receptor) locus during myeloid differentiation
The effect of telomerase RNA mutations found in dyskeratosis congenita and aplastic anaemia on telomerase activity reconstituted in vitro
Identification of a commitment point that controls entry into the cell cycle from a quiescent (G0) state
Nurse led anticoagulant teams are a safe and effective way of managing the loading and maintenance of warfarin in hospital inpatients and outpatients
Simple and effective oral vitamin K protocol for non-urgent warfarin reversal in a nurse-led anticoagulant service
Prospective evaluation of a regional protocol for rapid warfarin reversal in major haemorrhage
Failure of low molecular weight heparin to prevent thromboembolism in pregnant women with metal prosthetic heart valves
European concerted action on anticoagulation (ECAA). Correction of displayed INR on two point-of-care test (POCT) whole blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent International Sensitivity Index (ISI) calibration
European concerted action on anticoagulation (ECAA). Reliability of international normalized ratios (INR) from CoaguChek Mini and TAS PT-NC whole blood point-of-care test monitor systems
Which patients get international normalized ratios (INRs) of greater than 8.0?
A survey of anticoagulant services in the West of Scotland
Oral anticoagulation reduces tissue factor and soluble E selectin, but not IL6 in elderly patients with AF
Treatment of deep venous thrombosis in intravenous drug abusers
A programme for the point of care testing (POCT) of the ACT to ensure safe control of heparinization in coronary angioplasty
Preliminary data from the Medical Devices Agency (MDA) study of the CoaguCheck S in a patient self-testing environment
Indo-Asians and Afro-Caribbeans on warfarin attend more frequently than Europeans
Random global amplification (RGA) of cDNA libraries from small amount of RNA maintains the original transcripts ratios
Mesenchymal stem cells (MSC) isolated by plastic adherence show reduced proliferative capacity and average telomere length with donor age
Lymphocytes produce an adiponectin-like inhibitor of granulopoiesis
Molecular genetic analysis of monocyte esterase deficiency
Protein delivery into primary haemopoietic cells
Up-regulation of HOXA9 and HOXA10 in myeloid cell lines following short-term HDAC inhibitor and ATRA treatment
Could ABCG2 be used as an alternative to CD34 as a haemopoietic stem cell marker?
The effect of thiopurine methyltransferase on the cytotoxic action of thiopurine drugs
Acute myeloid leukaemia with t(8;16)(p11;p13)
AML1-ETO acts as a sequence specific transcriptional repressor in vivo by altering the chromatin structure of target genes
Erythropoietin receptor expression is modulated by hypoxia in multiple myeloma cell lines
Serial longitudinal measurements of telomere length of peripheral blood leucocytes in human foetuses reveals altered dynamics of telomere decline compared to post natal and adult blood cells
Vascular endothelial growth factor (VEGF) activates nuclear factor κB in chronic lymphocytic leukaemia (CLL) cells
Disassociation of the effects of Vitamin D3 on proliferation and differentiation of normal cells by an agonist of PPARalpha
Phenotypic analysis of CD56dim+ and CD56bright+ natural killer cell subsets. Evidence for distinct subsets with differential roles in innate immunity
Developments in digital imaging for UK NEQAS(H) blood cell morphology scheme
Clinical characteristics, prognostic factors and survival of 36 adult patients with acute promyelocytic leukaemia
Assessement of neutrophil apoptosis ex vivo in hepatosplenic patients with neutropenia pre and post splenectomy
5-Androstenediol and 5-Androstenetriol stimulate neutrophil and platelet production in myelosuppressed cynomolgus macaques
Human bone marrow oxygen transport model
Systemic mastocytosis
Relative neutropenia and lymphocyte subsets in healthy adult Kuwaiti Arabs
Audit of Midazolam sedation for bone marrow biopsy at Southampton University Hospitals Trust
Thrombocytosis and its management in pregnancy
Finasteride — a useful agent for treatment of polycythaemia
Impact of the two week wait initiative on referral patterns for haematological malignancies in South Devon
Antibacterial resistance in Gram-negative bacteria recovered from haemato-oncology patients
Ethylenediaminetetraacetic acid plus citrate, theophylline, adenosine and dipyridamole (EDTA CTAD) a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood
Comparison of different hormone replacement therapies (HRT) agents on haemostatic markers of endothelial function
Management of pulmonary embolism
The role of recombinant factor VIIa in the management of severe haemorrhage requiring massive blood transfusion
What is a safe cut-off level for a D-dimer assay, used as part of a screening programme for deep venous thrombosis (DVT)?
Validation of the Taipan snake venom assay in routine practice to assess lupus anticoagulant status in patients being assessed for lupus anticoagulant
Management of intravenous drug users with venous thromboembolism
Inferior venal caval filters (IVC)
Difficulty of confirming or refuting a bleeding disorder just based on the clinical history alone
A transient factor V inhibitor associated with vasculitis
An evaluation of the real-life diagnosis and management of heparin-induced thrombocytopenia
Validation of Taipan snake venom time in lupus anticoagulant testing in patients receiving warfarin
Study of VWF antigen clearance in patients with type I von Willebrand disease and reporting of a familial tendency
Identification of four novel mutations in patients with FX deficiency, implications for future mutation screening
A normal prothrombin level does not appear to exclude the presence of the prothrombin gene mutation
Von Willebrand factor cleaving protease levels are reduced in acute coronary syndromes
Fibrinogen gene mutations causing dysfibrinogenaemia are associated with variable phenotypes
−455G/A beta-fibrinogen gene polymorphism and venous thromboembolism
Screening for thrombophilia
A second case of platelet ultrastructural defect indicated by Bayer ADVIA 120 measurement of a low mean platelet component concentration
The expression of monocyte tissue factor during pregnancy
Endothelial damage/dysfunction and abnormal thrombogenesis are related to ‘nondipping’ pattern of nocturnal blood pressure in patients with coronary artery disease
An introduction to VERITY, a national VEenous thromboembolism RegIsTrY examining management and outcomes of venous thromboembolic disease treated with low molecular weight heparin (enoxaparin)
Platelet, coagulation and endothelial markers in primary thrombocythaemia
Acute monoblastic leukaemia presenting with hypofibrinogenaemia and hyperfibrinolysis
Platelet function in hypertension and cardiovascular disease
Fludarabine/Cyclophosphamide (FC) with or without Rituximab is more active than CHOP in Mantle Cell Lymphoma (MCL)
High frequency of cytomegalovirus-specific CD4+ T cells in patients with B-cell chronic lymphocytic leukaemia
No effect of P2X7 receptor polymorphism on risk of CLL or on outcome from therapy in the UK population
Genetic polymorphisms in glutathione S-transferase mu (GSTM1) and theta (GSTT1) in multiple myeloma and MGUS
The pattern of expression of the apoptotic inducer FAS and the apoptotic inhibitor BCL-2 oncogenes immunohistogenically in bone-marrow invaded by the non-Hodgkin lymphomas
The use of granulocyte colony stimulating factor (G-CSF) to support adherence to the 14-day CHOP regimen in patients >60 years
Plasma cell leukaemia following essential thrombocythemia treated with hydroxyurea and busulphan
Predictors of length of first complete remission in new patients with secretory myeloma
Amplification of AML1 on a duplicated chromosome 21 defines a new patient subgroup in acute lymphoblastic leukemia
The gain of chromosome 5 in acute lymphoblastic leukaemia
Secretion of factor(s) that inhibit T cell activation in B cell chronic lymphocytic leukaemia (B-CLL) is associated with clinically aggressive disease and lack of mutation in immunoglobulin variable heavy (IgVh) chain genes
Morphological examination, using light and electron microscopy, demonstrate lymphocyte apoptosis and subsequent phagocytosis, following exposure to extracorporeal photopheresis
An open, randomized, phase II, single centre, two-period cross over study to compare the quality of life (QoL) and toxicity experienced on PEG Interferon (P-IFN) with Interferon-alpha2b (IFN) in patients with myeloma maintained on a steady dose of IFN
Variations in asparagine synthetase levels in blasts from patients with acute leukaemia
Expression profiling identifies distinct patterns associated with karyotype in acute myeloid leukaemia
A rapid molecular response to imatinib correlates with superior outcome in Chronic Myeloid Leukaemia (CML)
Elevated levels of WT1 transcripts in post induction bone marrow samples at remission predict high relapse risk in acute myeloid leukaemia
Dendritic cell-leukaemic blast fusion hybrids as potential T-cell stimulators for immunotherapy in AML
Relationship between phenotypic/functional protein and gene expression in drug-resistance and apoptosis-associated proteins in AML
The diagnosis and classification of leukaemia using a small customized, oligonucleotide microarray
Dendritic cells fused with autologous myeloid leukaemia (AML) blast cells generate tumour-specific T-cell cytotoxicity
Four-colour flow-cytometric analysis of acute myeloid leukaemia of monocytic lineage
The mononucleotide microsatellites BAT-25 and BAT-26 are not sensitive indicators of the replication error phenotype in AML
The inhibitory effect of tumour-derived soluble factors on T-cell activation and proliferation is dependant on disease stage
Real-time quantitative analysis of minimal residual disease in Inv(16)positive AML patients. A comparison of WT1 and CBFB/MYHII transcripts
Enhanced cytotoxicity of doxorubicin and etoposide by polysaccharide peptide (PSP) in HL-60 cells
Episodic clusters of stenotrophomonas infection on an Adult Leukaemia Unit at Christie Hospital
Real-time quantification of antiapoptotic genes (SURVIVIN, BCL2 and TUCAN) in AML and normal mononuclear cells
Vincristine neuropathy in children on different treatment regimes for ALL
Evaluation of a point-of-care coagulation device (Rapidpoint Coag), in measurements of prothrombin time and activated partial thromboplastin time in a neonatal unit
Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukaemia (ALL)
Neuro-developmental delay in infants with sickle cell disease
Langerhans cell histiocytosis
Haploidentical transplantation with stem cell ‘boosts’ and T-cell addbacks for mixed chimaerism
Recombinant FVIIa for surgical bleeding in childhood
Stem cell ‘boosts’ following haploidentical transplantation for poor immune reconstitution
Attainment of lymphopenia (but not thrombocytopenia or neutropenia) during maintenance therapy predicts continuing remission especially in low-risk acute lymphoblastic leukaemia (ALL)
Adverse events in paediatric patients reported to SHOT, 1996–2001
Simultaneous clinical scale isolation and expansion of CD4+ and CD8+ virus-specific T cells using interferon-gamma secretion
Homing of cytokine-manipulated transduced stem cells is improved following non-myeloablative conditioning regimens but is severely impaired by cytokine manipulation
Adhesion of platelets to cryopreserved CD34+ peripheral blood stem cells results in misleadingly high annexin V measurements
Salvage therapy using nonmyeloablative second allograft for engraftment failure following first allogeneic stem cell transplant in haematological malignancy
Long-term outcome of myeloma patients treated with an elective single autograft with follow-up (5 years)
Early CD8 and CD4 cell recovery predicts survival post autologous stem cell transplantation for lymphoma
Role of CMV viral load quantitation using TAQMANTM real time CMV PCR (TaqmanTM CMVQ PCR) in the effective monitoring of CMV following stem cell transplantation
The place of voriconazole in the practical management of neutropaenia/BMT patients
Chimerism analysis following allogeneic stem cell transplantation by real-time quantitative PCR using single nucleotide polymorphisms (SNP)
Non-myeloablative sibling stem cell transplantation to cure severe Bernard Soulier Disease
Increased incidence of granulomas in bone marrow trephines following alemtuzumab treatment
Plasminogen activators
The use of rituximab, an anti-CD20 monoclonal antibody, in adults with immune thrombocytopenic purpura
Thrombolytic properties of normal human neutrophils
Ximelagatran, and its subcutaneous form melagatran, versus enoxaparin as thromboprophylaxis in total hip or total knee replacement
A novel r-polypeptide, Kunitz-type inhibitor with high specificity for plasma kallikrein and potential for therapeutic use
Prothrombotic states and primary pulmonary hypertension
The effect of pathogen inactivation treatment processes on VWF cleaving protease, VWF
Survival and complications in a cohort of neonatally screened children with sickle cell disease in East London
Screening for sickle retinopathy
Prediction of blood use in a cardiac surgical unit
Hydrops fetalis resulting from apparently insignificant levels of alloimmune anti-D
Reducing red cell transfusion by audit and education in a large teaching hospital
Real time PCR is superior to ELISA for the early detection of invasive fungal infection in haematology patients
Role of FDG-PET scanning in the management of Hodgkin and non-Hodgkin lymphoma after reduced intensity allografting
Temozolomide-mediated in vivo selection of alkyltransferase-transduced allogeneic donor stem cells in murine MHC mismatched chimeras established using a non-myeloablative protocol
Genotyping of non-HLA loci accurately predicts outcome following sibling allogeneic bone marrow transplant in patients with chronic myeloid leukaemia
Outcome following allogeneic transplantation for AML/MDS using in vitro alemtuzumab for T cell depletion
Reduced-intensity allogeneic transplantation using BEAM-Campath in patients with lymphoproliferative diseases – GVHD, toxicity and survival in 65 patients
FISHing for chromosomal abnormalities of prognostic significance in the MRC childhood acute lymphoblastic leukaemia (ALL) treatment trial, ALL97
The vitamin D3 analogue, EB1089, defines a novel class of therapeutic agents for the treatment of B-cell chronic lymphocytic leukaemia
Frizzled-related protein (FRZB) and signalling via the Wnt pathway are implicated in the pathogenesis of multiple myeloma (MM)
Regulatory cell mediated immunosuppression in Hodgkin lymphoma
Single agent thalidomide has significant activity in mantle cell lymphoma
The development of targeted chemotherapy for CNS lymphoma
Cyclin D2 controls B cell progenitor numbers
Altering FUS (TLS) expression changes the response to induced differentiation, which is dependent on the cytogenetic abnormality in leukaemia cell lines
The regulation of ERIC-1, an erythropoietin induced gene
T cell effector functions can be induced in G0 and do not require entry into the cell cycle
Congenital pulmonary alveolar proteinosis is associated with disruption of GMCSF beta subunit signalling by a secreted receptor
DNA microarray analysis with small numbers of haematopoietic cells
Regulation of HOXA5 and HOXA9 by IL-3 in 32D cells
Aberrant chaperonin expression (HSP70, Hsc70 and gp96) in cell lines and primary cells from CML and myeloma patients prior to and in response to stress
The co-expression of P-glycoprotein suppresses apoptosis induced by Flt3 inhibitors in AML with Flt3 internal tandem duplications
A small proportion of mesenchymal stem cells (MSC) strongly express functionally active CXCR4 receptor capable of promoting migration to bone marrow
X-inactivation patterns of closely, but not distantly, related cells are highly correlated
A potentially novel site for etoposide-induced tyrosine phosphorylation of cyclin dependent kinase 1 in myeloid leukaemia cell lines
Induced expression of defensin sense and antisense cDNA in acute promyelocytic leukaemia cell lines
Thalidomide analogues down-regulate VEGF and IL-6 production in co-cultures of myeloma and endothelial cells
Efficacy and safety of ultrasound guided (USG) core biopsy of the spleen
Bone marrow aspirate and trephine
Limitation of transfusional iron loading in congenital non-spherocytic haemolytic anaemia by the use of regular automated red cell exchange transfusion
Outcome of patients with haematological malignancy transferred to intensive care unit
Place of death in patients with haematological malignancy
A new route for scientists in haematology
Induction of apoptosis in megakaryocytic cell lines by hydroxyurea, aspirin and its metabolite, salicylic acid
Bone morphogenetic protein-6 enhances the combination of parathyroid hormone and vitamin D3-induced osteogenic differentiation of bone marrow-derived human mesenchymal stem cells
Low B12 levels
Evaluation of automated differentials on body fluids
The outcome of screening an antenatal population at booking for iron and haemoglobinopathy status
The immunomodulating effect of a Chinese medicinal herb extract, polysaccharide peptide (PSP), in humans
Evaluation of a clinical algorithm in nurse led DVT management to identify underlying malignancy
The relationship between APTT and lupus anticoagulants
Platelet activation and angiogenesis in sickle cell disease
Heparin induced thrombocytopaenia (HIT) – a 5-year review
Soluble P selectin must be measured in plasma, not in serum
Successful eradication of an inhibitor in a patient with mild haemophilia A using combined modality therapy monitored by two different methods
Why do dangerously high INRs occur?
A multi-centre study of the endogenous thrombin potential using a continuous monitoring chromogenic technique
Use of plasma spiked with monoclonal antibodies in lupus anticoagulant (LA) screening; experience with the UK NEQAS (Blood Coagulation) proficiency testing programme
The role of anticardiolipin antibodies (aCL) in the diagnosis of the antiphospholipid syndrome
FXI deficiency associated with heterozygosity for a novel Cys 28 Phe substitution
The MDA study of rapid D-dimer assays for the exclusion of venous thromboembolism
Thrombophilia in pregnancy, combined oral contraceptives and hormone replacement therapy users
Very low-density lipoprotein enhances the anticoagulant activity of activated protein C in sepsis
Acquired resistance to activated protein C is more pronounced in women receiving combined oral contraceptives containing desogestrel than levonorgestrel and is associated with low protein S levels
The prevalence and significance of IgM antibodies to beta 2 glycoprotein 1 in patients with anti-phospholipid syndromes
The risk of thromboembolism and the effectiveness of prophylactic treatment in thrombophilia patients undergoing major orthopaedic surgery
Abnormal thrombogenesis and endothelial damage/dysfunction is related to high pulse pressure in patients with coronary artery disease
Mutation analysis in 32 families with haemophilia A
Routine coagulation screening to predict surgical bleeding is frequently misleading, of no significant clinical value and should be abandoned; results of a systematic review
Accuracy of a pre-test questionnaire in excluding deep vein thrombosis (DVT)
The influence of blood group genotypes on APC resistance, thrombin generation and foetal development in pregnancy
Association between apolipoprotein E genotype and stroke
Factor V Leiden detection by polymerase chain reaction-restriction fragment length polymorphism with mutagenic primers in a multiplex reaction with pro G20210A - a novel technique
Use of thrombelastography for perioperative monitoring of enoxaparin
TNF haplotype is an independent prognostic factor in patients with B-cell non-Hodgkin's Iymphoma
Serum free light chain levels in patients with intact immunoglobulin myeloma
The incidence of non-Hodgkin's lymphoma is not continuing to increase
Immunohistochemical detection of P53, retinoblastoma, bcl-2 proteins in primary mediastinal large B cell lymphoma
Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe
Anaplastic large cell lymphoma of the bone marrow
The use of cyclin D1 mRNA transcript quantification to monitor disease levels in the peripheral blood of mantle cell lymphoma patients undergoing therapy. Preliminary findings
Rituximab plus liposomal vincristine for the treatment of large B-cell lymphoma in the elderly
Serum free light chain assays provide improved monitoring of myeloma therapy
ABL amplification in acute lymphoblastic leukaemia
Vascular endothelial growth factor (VEGF) up-regulates Hsp90 expression in CLL cells
Longer-term analysis of thalidomide-treatment in myeloma patients and predictive utility of pre-treatment CRP and beta 2 microglobulin
Primary bladder lymphoma
Micro-array gene expression signatures for the prediction of clinical parameters in AML
Identification of genes related to the age of diagnosis of AML patients under 60 years old
Imatinib mesylate in myelofibrosis
Imatinib (STI571, Glivec) for chronic Ph-negative myeloproliferative disorders associated with eosinophilia
Proteasome activity is elevated in leukaemia
Association of karyotypic abnormalities with survival and transformation in stratified MDS patients
The use of growth factor cocktails to improve cytogenetic analysis of bone marrow cultures from patients with myeloproliferative disorders (MPD) and myelodysplastic syndromes (MDS)
An investigation of the MEK/ERK inhibitor U0126 in acute myeloid leukaemia
The DNA repair protein Rad51 is overexpressed in AML and is also up-regulated further following chemotherapy
Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia (AML)
PML/RARA-targeting DNAzymes suppress proliferation and induce apoptosis in ATRA-sensitive and ATRA-resistant APL cells
cDNA microarray screening of constitutive gene expression in bone marrow samples from normal, non-AML, AML patients and AML cell lines
The use of imatinib in the treatment of CML in Northern Ireland
Tumour supernatant (TSN) derived from myeloblasts inhibits the apoptosis of haematopoietic cells
Rare haemoglobin variants found in Irish patients
A direct comparison of pain experiences in children with sickle cell disease from East London and the Caribbean
Examination of flow cytometric histograms of eosin-5-maleimide labelled red cells can asist in differential diagnosis of membranopathy
Recessive congenital ethaemoglobinaemia in five Irish families
Chuvash-type congenital polycythaemia identified in four families of Asian and Western European ancestry
Soluble P-selectin and sICAM correlates with blood transfusion iron overload in sickle cell disease
Multiplex PCR detection of alpha thalassaemia deletional mutations in a population of antenatal patients
Prevalence of anaemia in couples coming to marriage consultation center in Hashtgerd Health Center in 1999
HTLV 1/2 in blood donors in Scotland. The effect of leucocyte depletion of blood components and the value of donation archive samples
Failure to prescribe irradiated blood components is significantly under-reported
The South East Thrombotic Thrombocytopenic Purpura (TTP) study group
HIV testing of blood donations in Scotland and Northern Ireland. Implications and actions following an increase in HIV positive results in 2002
Setting up pre-operative autologous donation in a large NHS Trust
Cost-effectiveness of rituximab in refractory cold haemagglutinin disease
Transfusion associated bacterial contamination
Safe and effective transfusion in Scottish hospitals
Sustaining a stringent prophylactic platelet transfusion policy
An audit of red cell and blood product use after institution of thromboelastography in a cardiac intensive care unit
The impact of screening a platelet donor panel for HLA antibodies to reduce the risk of transfusion-related acute lung injury (TRALI)
Impact of TRALI on the cost-effectiveness of solvent detergent-treated fresh frozen plasma (Octaplas)
Drug-induced autoimmune haemolytic anaemia associated with Mefloquine anti-malarial prophylaxis
How can the Serious Hazards of Transfusion (SHOT) scheme support better blood transfusion?
Fludarabine maximization for stem cell transplantation in children with mucopolysaccharidoses-1H, Hurler syndrome
Prognostic factors at the time of autotransplantation with 200 mg/m2 melphalan
Fludarabine phosphate and melphalan — an immunosuppressive reduced intensity conditioning (RIC) regimen for allogeneic stem cell transplantation in patients with a range of haematological malignancies
Measurements of pre-treatment cyclosporin (CSA) metabolite ratios do not predict the incidence of graft-versus-host disease but may predict the onset of renal dysfunction
Use of the BSBMT registry to benchmark transplant outcome in the UK/Ireland against the EBMT database
Fifteen-year single centre experience of autologous stem cell transplantation for Hodgkins disease — factors associated with improved survival for recently transplanted patients
Comparison of three mobilization regimens in patients with multiple myeloma
Comparison of second autograft and nonmyeloablative allograft as therapy for myeloma following relapse post autograft
Potency of the graft versus leukaemia (GVL) effect following unrelated donor cord blood (CB) transplant
Marrow cellularity is predictive of CD34+ bone marrow harvest yield
Mono- and biclonal gammopathies following conditioning regimens incorporating alemtuzumab for haemopoietic stem cell transplantation (SCT)
Eculizumab, a C5 complement blocking antibody, is the first therapy to reduce transfusion requirements in patients with paroxysmal nocturnal haemoglobinuria (PNH)
The induction of tolerance to RhD in HLA DR15 transgenic mice
A humanized monoclonal antibody against vWF A1 domain inhibits vWF
Phase I study of the adoptive transfer of tetramer selected cytomegalovirus-specific cytotoxic T cells after allogeneic stem cell transplantation
Bone marrow mesenchymal stromal cells protect chronic lymphocytic leukaemia (CLL) from spontaneous and drug-induced apoptosis
Targeting FGFR3 in multiple myeloma
Decreased expression of a novel growth regulatory protein, Nov, in chronic myeloid leukaemia
Reduced hTR expression in CML CD34+ cells at diagnosis
Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) using fludarabine, busulphan and alemtuzumab conditioning in 63 patients with myelodysplastic syndromes (MDS)
Combined clofibric acid and medroxyprogesterone acetate exert multiple anti-leukaemic actions against acute myeloid leukaemia cells and cell lines
The utility of in vitro testing for imatinib sensitivity in BCR-ABL negative myeloproliferative disorders
Identification of a novel gene, GEMS, that is fused to FGFR1 in the 8p11 myeloproliferative syndrome
Venous thromboembolism (VTE) associated with the management of acute thrombotic thrombocytopenic purpura (TTP)
Results of D-dimer in the UK NEQAS (Blood Coagulation) proficiency testing programme
Progression of liver disease in hepatitis C infected haemophiliacs assessed by serial liver biopsy
UK surveillance of acquired haemophilia A
Procoagulant changes in human macrophages induced by environmental microparticles [PM10],
Is early activation of the clotting cascade involved in the pathogenesis of verotoxin-producing Escerichia coliassociated haemolytic uraemic syndrome?
Anti-D immunoglobulin in the treatment of immune thrombocytopenic purpura in adults in the United Kingdom
Reduced numbers and antigen unresponsiveness of natural killer T-cells in idiopathic (autoimmune) thrombocytopenia (ITP)
Outcome heterogeneity in childhood high hyperdiploid acute lymphoblastic leukaemia
Correction of the anaemia of chronic disease (ACD) with small doses of recombinant erythropoietin
Epidemiological evidence for an infectious origin for childhood leukaemia